2-FMA Stats & Data

2-FMA emerged on the online research chemical market in August 2007, appearing alongside other fluorinated amphetamines such as 2-FA and 4-FA. That same month, forensic analysis of capsules delivered to Royal Adelaide Hospital in Australia revealed the presence of 2-FMA. The capsules appeared to have originated from Neorganics, an Israeli company that was distributing drug-containing capsules internationally under various brand names, with the 2-FMA-containing product marketed as "Sub Coca 2." Analysis found the capsules contained 2-FMA in combination with α-phthalimidopropiophenone. Despite its early appearance on the market, 2-FMA remained relatively obscure for several years. The substance was first reported to the European Monitoring Centre for Drugs and Drug Addiction in 2012, with most user reports emerging from 2013 onward. An analysis of 162 seized drug samples in Italy between September 2013 and June 2015 found 2-FMA present in only a small number of samples, indicating its limited prevalence compared to other novel psychoactive substances during this period. The compound remains unknown in clinical and research literature, with virtually no formal pharmacological studies published. At least one fatality has been reported in connection with 2-FMA, though in that case the substance appeared to have been mislabeled. A male in his early twenties who had purchased what he believed to be 4-FMA online used it in combination with 3-MMC and codeine/acetaminophen tablets. He became unresponsive within minutes of administration and could not be resuscitated by paramedics. Subsequent toxicological analysis determined the substance was actually 2-FMA rather than 4-FMA, highlighting the risks associated with mislabeled research chemicals purchased from online vendors. Within online drug communities, 2-FMA has gained some attention as a component of the "Borax Combo," a combination designed to produce effects similar to MDMA. One common formulation combines 2-FMA with 5-MAPB and 4-HO-MET, with 2-FMA serving primarily to provide the stimulant component of the mixture.